Skip to main content

Aligos Therapeutics Inc. Common Stock (ALGS)

About The Company

ALGS Stock Market Logo

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company’s pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

IPO Year Sector Industry
2020 Health Care Biotechnology: Pharmaceutical Preparations

Aligos Therapeutics Inc. (ALGS) Latest News

Company Contact & Address (ALGS)

Corporate Headquarters Phone Website
ONE CORPORATE DRIVE 2ND FLOOR,
SOUTH SAN FRANCISCO,
California,
94080,
United States
+1 800 466-6059 Official ALGS Website

ALGS Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ALGS

Jobs & Employment at Aligos Therapeutics Inc.

LinkedIn Company Page https://be.linkedin.com/company/aligos-therapeutics
Official Career & Employment Page Employment & Careers at Aligos Therapeutics Inc. (ALGS)

Related & Similar Stock Symbols

VAXX Stock Market Price & News

VAXX

Vaxxinity Inc. Class A Common Stock

MPRAU Stock Market Price & News

MPRAU

Mercato Partners Acquisition Corporation Unit

ADILW Stock Market Price & News

ADILW

Adial Pharmaceuticals Inc Warrant